Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants

Courtney Voss, Sally Esmail, Xuguang Liu, Michael J. Knauer, Suzanne Ackloo, View ORCID ProfileTomonori Kaneko, Lori Lowes, Peter Stogios, Almagul Seitova, Ashley Hutchinson, Farhad Yusifov, Tatiana Skarina, Elena Evdokimova, Peter Loppnau, Pegah Ghiabi, Taraneh Haijian, Shanshan Zhong, Husam Abdoh, Benjamin D. Hedley, Vipin Bhayana, Claudio M. Martin, Marat Slessarev, Benjamin Chin-Yee, Douglas D. Fraser, Ian Chin-Yee, Shawn S-C. Li
doi: https://doi.org/10.1101/2021.03.16.21253716
Courtney Voss
1Department of Biochemistry, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally Esmail
1Department of Biochemistry, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuguang Liu
1Department of Biochemistry, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Knauer
2Department of Pathology and Laboratory Medicine, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Ackloo
3Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomonori Kaneko
1Department of Biochemistry, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomonori Kaneko
Lori Lowes
2Department of Pathology and Laboratory Medicine, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Stogios
4Department of Chemical Engineering and Applied Chemistry, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Almagul Seitova
3Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Hutchinson
3Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farhad Yusifov
3Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana Skarina
4Department of Chemical Engineering and Applied Chemistry, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Evdokimova
4Department of Chemical Engineering and Applied Chemistry, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Loppnau
4Department of Chemical Engineering and Applied Chemistry, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pegah Ghiabi
4Department of Chemical Engineering and Applied Chemistry, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taraneh Haijian
4Department of Chemical Engineering and Applied Chemistry, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shanshan Zhong
1Department of Biochemistry, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Husam Abdoh
2Department of Pathology and Laboratory Medicine, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin D. Hedley
2Department of Pathology and Laboratory Medicine, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vipin Bhayana
2Department of Pathology and Laboratory Medicine, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio M. Martin
5Department of Medicine, Western University, London, Ontario N6G 2V4
6London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marat Slessarev
5Department of Medicine, Western University, London, Ontario N6G 2V4
6London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Chin-Yee
7Divison of Hematology, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas D. Fraser
5Department of Medicine, Western University, London, Ontario N6G 2V4
6London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
8Department of Pediatrics, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Chin-Yee
2Department of Pathology and Laboratory Medicine, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shawn S-C. Li
1Department of Biochemistry, Western University, London, Ontario N6G 2V4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sli@uwo.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

BACKGROUND The role of humoral immunity in the coronavirus disease 2019 (COVID-19) is not fully understood owing, in large part, to the complexity of antibodies produced in response to the SARS-CoV-2 infection. There is a pressing need for serology tests to assess patient-specific antibody response and predict clinical outcome.

METHODS Using SARS-CoV-2 proteome and peptide microarrays, we screened 146 COVID-19 patients plasma samples to identify antigens and epitopes. This enabled us to develop a master epitope array and an epitope-specific agglutination assay to gauge antibody responses systematically and with high resolution.

RESULTS We identified 54 linear epitopes from the Spike (S) and Nucleocapsid (N) protein and showed that epitopes enabled higher resolution antibody profiling than protein antigens. Specifically, we found that antibody responses to the S(811-825), S(881-895) and N(156-170) epitopes negatively or positively correlated with clinical severity or patient survival. Moreover, we found that the P681H and S235F mutations associated with the coronavirus variant B.1.1.7 altered the specificity of the corresponding epitopes.

CONCLUSIONS Epitope-resolved antibody testing not only offers a high-resolution alternative to conventional immunoassays to delineate the complex humoral immunity to SARS-CoV-2 and differentiate between neutralizing and non-neutralizing antibodies, it may also be used as predictor of clinical outcome. The epitope peptides can be readily modified to detect antibodies against variants in both the peptide array and latex agglutination formats.

FUNDING Ontario Research Fund (ORF)-COVID-19 Rapid Research Fund, the Toronto COVID-19 Action Fund, Western University, the Lawson Health Research Institute, the London Health Sciences Foundation, and the AMOSO Innovation Fund.

Competing Interest Statement

SE, CV, XL and SSCL are inventors in a provisional patent submitted by Western University

Funding Statement

Grant funding to support research: Ontario Research Fund (ORF)-COVID-19 Rapid Research Fund, the Toronto COVID-19 Action Fund, Western University, the Lawson Health Research Institute, the London Health Sciences Foundation, and the AMOSO Innovation Fund. No external funding received for data monitoring board, study design, manuscript preparation, or statistical analysis

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Blood samples were collected following a protocol (study number: 116284) approved by the Research Ethics Board (REB) of Western University. The plasma samples were de-identified prior to transfer from the Laboratory of Clinical Medicine (London Health Sciences Center, London, Canada) to a biosafety Level 3 (CL3) lab (ImPaKT, Western University) following Transportation of Dangerous Goods (TDG) guidelines. All plasma samples were heat-inactivated at 56 oC for 30 minutes at the ImPaKT CL3 facility as per Western university biosafety regulation. Heat inactivated plasma samples were then transferred to the testing laboratory. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Supplementary data available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 20, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants
Courtney Voss, Sally Esmail, Xuguang Liu, Michael J. Knauer, Suzanne Ackloo, Tomonori Kaneko, Lori Lowes, Peter Stogios, Almagul Seitova, Ashley Hutchinson, Farhad Yusifov, Tatiana Skarina, Elena Evdokimova, Peter Loppnau, Pegah Ghiabi, Taraneh Haijian, Shanshan Zhong, Husam Abdoh, Benjamin D. Hedley, Vipin Bhayana, Claudio M. Martin, Marat Slessarev, Benjamin Chin-Yee, Douglas D. Fraser, Ian Chin-Yee, Shawn S-C. Li
medRxiv 2021.03.16.21253716; doi: https://doi.org/10.1101/2021.03.16.21253716
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants
Courtney Voss, Sally Esmail, Xuguang Liu, Michael J. Knauer, Suzanne Ackloo, Tomonori Kaneko, Lori Lowes, Peter Stogios, Almagul Seitova, Ashley Hutchinson, Farhad Yusifov, Tatiana Skarina, Elena Evdokimova, Peter Loppnau, Pegah Ghiabi, Taraneh Haijian, Shanshan Zhong, Husam Abdoh, Benjamin D. Hedley, Vipin Bhayana, Claudio M. Martin, Marat Slessarev, Benjamin Chin-Yee, Douglas D. Fraser, Ian Chin-Yee, Shawn S-C. Li
medRxiv 2021.03.16.21253716; doi: https://doi.org/10.1101/2021.03.16.21253716

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (501)
  • Anesthesia (110)
  • Cardiovascular Medicine (1233)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10012)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2448)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1636)
  • Health Policy (751)
  • Health Systems and Quality Improvement (635)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11860)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2277)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (453)
  • Occupational and Environmental Health (534)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4828)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)